Boston Scientific EBITDA 2006-2020 | BSX

Boston Scientific annual and quarterly EBITDA history from 2006 to 2020. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Boston Scientific EBITDA for the quarter ending June 30, 2020 was $-0.070B, a 118.23% decline year-over-year.
  • Boston Scientific EBITDA for the twelve months ending June 30, 2020 was $668M, a 59.07% decline year-over-year.
  • Boston Scientific 2019 annual EBITDA was $2.633B, a 8.13% increase from 2018.
  • Boston Scientific 2018 annual EBITDA was $2.435B, a 14.16% increase from 2017.
  • Boston Scientific 2017 annual EBITDA was $2.133B, a 67.56% increase from 2016.
Boston Scientific Annual EBITDA
(Millions of US $)
2019 $2,633
2018 $2,435
2017 $2,133
2016 $1,273
2015 $505
2014 $619
2013 $1,285
2012 $1,307
2011 $2,339
2010 $2,042
2009 $-48
2008 $2,149
2007 $925
2006 $-2,168
2005 $1,282
Boston Scientific Quarterly EBITDA
(Millions of US $)
2020-06-30 $-70
2020-03-31 $146
2019-12-31 $209
2019-09-30 $383
2019-06-30 $384
2019-03-31 $541
2018-12-31 $318
2018-09-30 $389
2018-06-30 $391
2018-03-31 $408
2017-12-31 $319
2017-09-30 $377
2017-06-30 $225
2017-03-31 $364
2016-12-31 $140
2016-09-30 $348
2016-06-30 $-334
2016-03-31 $293
2015-12-31 $-227
2015-09-30 $-299
2015-06-30 $219
2015-03-31 $24
2014-12-31 $-493
2014-09-30 $64
2014-06-30 $-69
2014-03-31 $197
2013-12-31 $127
2013-09-30 $103
2013-06-30 $220
2013-03-31 $-330
2012-12-31 $117
2012-09-30 $-594
2012-06-30 $-3,587
2012-03-31 $196
2011-12-31 $171
2011-09-30 $174
2011-06-30 $237
2011-03-31 $322
2010-12-31 $348
2010-09-30 $251
2010-06-30 $231
2010-03-31 $-1,486
2009-12-31 $-1,231
2009-09-30 $51
2009-06-30 $275
2009-03-31 $11
2008-12-31 $-2,416
2008-09-30 $28
2008-06-30 $303
2008-03-31 $580
2007-12-31 $-429
2007-09-30 $-147
2007-06-30 $280
2007-03-31 $282
2006-12-31 $284
2006-09-30 $195
2006-06-30 $-3,925
2006-03-31 $497
2005-12-31 $465
2005-09-30 $-336
2005-06-30 $326
2005-03-31 $513
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $55.768B $10.735B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $177.124B 33.24
Medtronic (MDT) Ireland $134.640B 21.87
Stryker (SYK) United States $70.344B 27.28
Lonza Group Ag (LZAGY) Switzerland $46.044B 0.00
Baxter (BAX) United States $42.068B 25.73
Terumo (TRUMY) Japan $28.809B 36.83
Zimmer Biomet Holdings (ZBH) United States $28.652B 23.78
EssilorLuxottica Societe Anonyme (ESLOY) France $28.072B 0.00
ResMed (RMD) United States $25.339B 36.80
Sunny Optical Technology (SNPTF) China $20.401B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.905B 0.00
Bio-Rad Laboratories (BIO) United States $15.045B 68.05
Insulet (PODD) United States $13.389B 566.50
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.636B 51.04
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.061B 12.12
Canopy Growth (CGC) Canada $6.650B 0.00
Hill-Rom Holdings (HRC) United States $6.384B 15.84
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.311B 0.00
Neogen (NEOG) United States $4.168B 69.64
Haemonetics (HAE) United States $4.002B 26.67
ICU Medical (ICUI) United States $3.727B 28.58
Envista Holdings (NVST) United States $3.647B 24.87
Abcam (ABCZY) $3.548B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.538B 0.00
Agios Pharmaceuticals (AGIO) United States $2.913B 0.00
National Vision Holdings (EYE) United States $2.828B 439.63
NuVasive (NUVA) United States $2.699B 37.62
TG Therapeutics (TGTX) United States $2.058B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.013B 185.38
AtriCure (ATRC) United States $1.896B 0.00
MacroGenics (MGNX) United States $1.504B 0.00
Aphria (APHA) Canada $1.333B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aurora Cannabis (ACB) Canada $1.180B 0.00
Cerus (CERS) United States $1.172B 0.00
Omeros (OMER) United States $1.162B 0.00
Cardiovascular Systems (CSII) United States $1.092B 0.00
OraSure Technologies (OSUR) United States $1.041B 0.00
InMode (INMD) Israel $0.989B 24.94
Quanterix (QTRX) United States $0.945B 0.00
Lantheus Holdings (LNTH) United States $0.919B 12.73
Owens & Minor (OMI) United States $0.878B 19.67
PetIQ (PETQ) United States $0.877B 25.32
Phibro Animal Health (PAHC) United States $0.816B 16.26
Meridian Bioscience (VIVO) United States $0.791B 18.27
Vapotherm (VAPO) United States $0.743B 0.00
BioLife Solutions (BLFS) United States $0.721B 376.17
VAREX IMAGING (VREX) United States $0.649B 16.12
Surmodics (SRDX) United States $0.643B 70.52
Zynex (ZYXI) United States $0.628B 54.82
LeMaitre Vascular (LMAT) United States $0.602B 36.74
Eagle Pharmaceuticals (EGRX) United States $0.592B 83.19
Cytosorbents (CTSO) United States $0.407B 0.00
Viemed Healthcare (VMD) United States $0.404B 14.44
Neptune Wellness Solutions (NEPT) Canada $0.339B 0.00
HEXO (HEXO) $0.333B 0.00
Utah Medical Products (UTMD) $0.293B 25.16
InfuSystems Holdings (INFU) United States $0.270B 149.44
Organigram Holdings (OGI) Canada $0.235B 0.00
Female Health (VERU) United States $0.214B 0.00
Chimerix (CMRX) United States $0.201B 0.00
Bovie Medical (APYX) United States $0.176B 0.00
Exagen (XGN) United States $0.170B 0.00
Surface Oncology (SURF) United States $0.168B 0.00
Fonar (FONR) United States $0.168B 14.88
Wound Management Technologies (SMTI) United States $0.166B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.133B 0.00
Liberty Health Sciences (LHSIF) Canada $0.126B 0.00
Evolus (EOLS) United States $0.125B 0.00
Rockwell Medical (RMTI) United States $0.119B 0.00
Chembio Diagnostics (CEMI) United States $0.115B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Capricor Therapeutics (CAPR) United States $0.087B 0.00
MTech Acquisition (KERN) United States $0.086B 0.00
United-Guardian (UG) United States $0.071B 15.88
Nephros (NEPH) United States $0.068B 0.00
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Akers Biosciences Inc (AKER) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.038B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00